Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
Job Description Summary
Role Type: Onsite Working #LI-Onsite
Location: Cambridge, Massachusetts, United States
Relocation: Relocation assistance is available for this position
Join Novartis Oncology-OIT (Oncology Immune Therapies) group for an exciting opportunity to make a significant impact on cancer immunology.
As a key member of our dynamic, multidisciplinary team, you will contribute to the development of groundbreaking therapeutic modalities.
Your work will play a crucial role in advancing new therapies and bringing our innovative drugs to patients.
Job Description
Key Responsibilities:
• Support drug screening, novel target identification and validation, including working with replication-incompetent lentiviruses, mRNA-LNP, cell lines, primary cells, and tissues
• Develop and perform cell-based assays, flow cytometry, and biochemistry-based assays for drug discovery. Occasionally, you will also employ molecular biology (e.g. gel electrophoresis, cloning, qPCR, western blot, etc.)
• Conduct biological and pharmacological studies by developing and performing analyses of preclinical tissue samples provided by the in vivo team
• Employ good laboratory practices, data recording, analysis and documentation
• Collaborate effectively while working in a matrixed environment
• Present results in lab and department meetings
• Assist in writing research documents and publications
Essential Requirements:
• Bachelor’s degree in immunology, immuno-oncology, oncology, molecular or cell biology, or a related field is required. A master’s degree is preferred.
• 5+ years of relevant laboratory experience in industry
• Knowledge of immunology and expertise in cancer biology and/or immunology are required
• Expertise in tumor immunology, especially T cell mediated anti-tumor activity is highly desired
• Proficiency in cell culture including cell lines and primary cells, and multi-color flow cytometry is required.
• Extensive hands-on experience with immune cell-based assays, including primary immune cell isolation, manipulation, phenotyping, and in vitro functional assays, as well as mammalian cell line culture is highly desired.
• Experience with molecular cloning, qPCR, reporter assays, ELISA, viral production and transduction, mRNA-LNP–mediated gene expression in primary cells, gene silencing (RNAi or CRISPR), or other target validation methods is a plus.
• Demonstrated ability to quickly learn and perform in new areas, implement new techniques and instrumentation
• Strong scientific motivation and rigor, with experience independently designing, developing, executing, and troubleshooting cell-based assays for drug discovery, are preferred.
• Excellent presentation, written and verbal communication, and interpersonal skills, with the ability to thrive in a fast-paced, collaborative environment.
• A record of accomplishments with peer-reviewed publications a plus
What We Offer
This is a dual level posting and as such the salary for this position is expected to range between:
Senior Scientist I: $93,800 - $174,200 per year
Senior Scientist II: $98,700 - $183,400 per yea r
The final salary offered is determined based on factors like, but not limited to, relevant skills and experience, and upon joining Novartis will be reviewed periodically. Novartis may change the published salary range based on company and market factors.
Your compensation will include a performance-based cash incentive and, depending on the level of the role, eligibility to be considered for annual equity awards.
US-based eligible employees will receive a comprehensive benefits package that includes health, life and disability benefits, a 401(k) with company contribution and match, and a variety of other benefits. In addition, employees are eligi
Apply on employer site ↗